ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

29,294Medicare Part D Prescriptions Filled, Including Refills

Rank: 78 out of 3647

$1.55M Total Retail Price of All Prescriptions

Rank: 68 out of 3647

1,245 Patients Receiving at Least One Drug in Part D
49%Patients 65 Years and Older
75% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 1,245 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

28% of this provider’s 1,245 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

3% of this provider’s 13,686 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
HYDROCODONE-ACETAMINOPHEN 1,738 605 S3 1 12
SIMVASTATIN 1,006 615 2 1
TRAMADOL HCL 954 332 3 22
CEPHALEXIN 756 347 10 4 142
MELOXICAM 712 422 5 33
OMEPRAZOLE 692 379 6 3
LISINOPRIL 659 328 7 4
LEVOTHYROXINE SODIUM 516 233 8 5
METFORMIN HCL 508 219 9 6
AMLODIPINE BESYLATE 507 342 10 2
CIPROFLOXACIN HCL 507 184 10 53
NAPROXEN 483 179 12 70
ATENOLOL 461 269 13 10
ENALAPRIL MALEATE 449 239 14 35
ZOLPIDEM TARTRATE 446 225 15 14
AMPHETAMINE SALT COMBO 441 92 S2 16 397
FAMOTIDINE 434 253 17 61
PREDNISONE 372 175 18 43
FUROSEMIDE 366 215 19 8
METOPROLOL TARTRATE 357 239 20 7
FLUTICASONE PROPIONATE 343 162 21 32
PROAIR HFA 340 102 22 62
GABAPENTIN 324 106 23 17
RANITIDINE HCL 292 160 24 29
GLIPIZIDE ER 286 147 25 112
DOXEPIN HCL 277 99 26 282
CARISOPRODOL 258 24 R 27 115
HYDROCHLOROTHIAZIDE 248 138 28 9
ACETAMINOPHEN-CODEINE 241 46 S3 29 149
TAMSULOSIN HCL 218 145 30 28
CRESTOR 215 108 31 19
CITALOPRAM HBR 206 85 32 25
ATENOLOL-CHLORTHALIDONE 205 137 33 171
AMITRIPTYLINE HCL 191 92 R 34 105
GLIPIZIDE 189 98 35 41
CYCLOBENZAPRINE HCL 188 47 R 36 98
POTASSIUM CHLORIDE 185 128 37 24
SERTRALINE HCL 183 89 38 27
AZITHROMYCIN 180 84 39 34
NEXIUM 172 63 40 44
FLUOXETINE HCL 170 51 41 68
ALPRAZOLAM 166 75 42 31
TRAZODONE HCL 163 43 43 64
ACTOS 162 94 44 148
WARFARIN SODIUM 159 83 45 15
SPIRONOLACTONE 136 67 46 77
DIGOXIN 130 102 47 51
METOPROLOL SUCCINATE 126 89 48 18
FLUCONAZOLE 124 43 49 226
ISOSORBIDE MONONITRATE ER 123 78 50 56
ADVAIR DISKUS 122 52 51 52
FENOFIBRATE 121 44 52 50
CARTIA XT 118 79 53 242
SULFAMETHOXAZOLE-TRIMETHOPRIM 117 40 54 110
CLOTRIMAZOLE-BETAMETHASONE 116 71 55 84
PROMETHAZINE HCL 116 28 R 55 182
PENICILLIN V POTASSIUM 114 24 57 490
IBUPROFEN 113 49 58 55
LOVASTATIN 113 52 58 21
MOMETASONE FUROATE 112 64 60 321
PREMARIN 111 74 R 61 217
TRIAMTERENE-HCTZ 111 87 61 58
GLIPIZIDE XL 111 50 61 190
TORSEMIDE 110 70 64 215
CLONIDINE HCL 109 60 65 46
INSULIN SYRINGE 107 38 66 76
DIPHENOXYLATE-ATROPINE 104 58 67 448
METOCLOPRAMIDE HCL 104 33 67 135
LEVETIRACETAM 102 26 69 122
METHYLPHENIDATE HCL 101 29 70 534
ATORVASTATIN CALCIUM 99 68 71 13
DIOVAN 99 80 71 40
MECLIZINE HCL 97 67 73 85
ROPINIROLE HCL 96 21 74 151
RISPERIDONE 96 36 74 83
ALLOPURINOL 95 63 76 37
PLAVIX 94 66 77 39
PHENYTOIN SODIUM EXTENDED 93 33 78 199
ESTRADIOL 93 50 R 78 236
CARVEDILOL 93 52 78 20
BUPROPION HCL SR 88 15 81 249
MIRTAZAPINE 88 24 81 63
CELEBREX 87 50 83 111
CLOPIDOGREL 85 57 84 26
BACLOFEN 85 18 84 97
ABILIFY 85 0 84 205
LIDODERM 84 41 87 108
LYRICA 84 0 87 120
TRIAMTERENE-HYDROCHLOROTHIAZID 84 58 87 223
SINGULAIR 84 37 87 90
SPIRIVA 83 32 91 93
LACTULOSE 82 43 92 128
METOLAZONE 81 60 93 251
CYMBALTA 80 28 94 79
COMBIVENT 80 38 94 170
PAROXETINE HCL 80 35 94 60
SYMBICORT 78 28 97 153
MUPIROCIN 77 37 98 137
PIOGLITAZONE HCL 75 32 R 99 360
LISINOPRIL-HYDROCHLOROTHIAZIDE 74 16 100 36
MONTELUKAST SODIUM 73 30 101 160
METHOCARBAMOL 73 12 R 101 250
CILOSTAZOL 73 61 101 168
DICLOFENAC SODIUM 72 62 104 86
VOLTAREN 72 31 104 102
LANTUS 71 26 106 59
LOSARTAN POTASSIUM 70 66 107 11
VENLAFAXINE HCL ER 67 21 108 181
VENTOLIN HFA 67 0 108 88
ESCITALOPRAM OXALATE 64 29 110 65
KETOCONAZOLE 63 28 111 132
LANTUS SOLOSTAR 63 0 111 124
LANSOPRAZOLE 62 48 113 116
DILTIAZEM 24HR CD 61 40 114 155
NOVOLIN 70-30 61 12 114 130
HUMIRA 60 14 116 463
OXYCODONE-ACETAMINOPHEN 59 15 S2 117 91
CARBAMAZEPINE 57 19 118 308
OXYBUTYNIN CHLORIDE 57 32 118 107
TRICOR 56 41 120 144
NIFEDIPINE ER 56 54 120 67
GENERLAC 54 26 122 278
KLOR-CON M20 54 28 122 121
PANTOPRAZOLE SODIUM 53 34 124 38
HUMULIN 70-30 53 20 124 192
LAMOTRIGINE 52 0 126 266
PROPRANOLOL HCL 52 27 126 156
BETAMETHASONE VALERATE 52 33 126 582
ALBUTEROL SULFATE 51 15 129 157
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 18, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.